Oncology Focus : CAR-T and CAR-NK therapies represent ~30% of all cell and gene trials, with a strong focus on solid and hematological malignancies. Significant attention on gastrointestinal tract and ...

Phase 1: Discovery and Preclinical Phases: Identification and testing of potential drug compounds. Duration: 1 to 6 years.

Sanofi, Formation Bio and OpenAI have joined forces to build an AI-powered tool designed to improve drug development by ...

Objectives Secondary prevention of rheumatoid arthritis (RA) is generally considered potentially impactful because the entire ...

The academic members of the research team that conducted the clinical trial recently demonstrated in a preclinical model that therapeutic inhibition of FasL significantly increased survival of mice ...

Other causes of lung cancer are well known, like radon gas exposure, which happens to be fairly prevalent in Appalachia. It’s ...

Experts have identified a cannabis compound called cannabinol (CBN) that appears to significantly enhance sleep quality.

While A.I. promises breakthroughs, industry leaders warn that transparency and patient safety must remain front and center.

Drug distributor Cencora plans to buy Retina Consultants of America from Webster Equity Partners in a $4.6 billion deal.  | ...

Members of Medigene management as expert speakers, Prof. Dolores Schendel, Chief Scientific Officer and Kirsty Crame, MD, Vice President, Clinical Strategy & Development Presentations and seminars ...

NMS Capital has exited its investment in Flourish Research, a US-based clinical trial organization, through a sale to Genstar Capital. No financial terms were disclosed.